Skip to content
OpenCapital
Get started

Maravai LifeSciences Holdings, Inc. MRVI TriLink — Revenue

Similar metrics at other companies

BillionToOne, Inc. logo
BLLNClinical trial support and other services — Revenue
$1.14M+61.0%
Veracyte logo
VCYTBiopharmaceutical and other revenue — Total Revenue
$301K-91.6%
Veracyte logo
VCYTBiopharmaceutical revenue — Total Revenue
$301K-86.9%
Mirion Technologies logo
MIRLabs and research — Total revenues
$28.3M+5.6%
STERIS logo
STELife Sciences: — Revenue
$145.8M+6.9%
Revvity logo
RVTYTotal Revenue
$711.12M+7.0%

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+204%
Enterprise value$954.59M+198%
P/S4.2×+3.0×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s trilink — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s trilink — revenue?
Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — revenue of $47.48M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s trilink — revenue changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s trilink — revenue increased by 65.1% year-over-year, from $28.75M to $47.48M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s trilink — revenue?
Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s trilink — revenue has grown at a -36.0% compound annual growth rate (CAGR), from $712.52M to $119.79M.
What does trilink — revenue mean?
This represents the total gross income generated by the Nucleic Acid Production segment through the sale of products and services. It serves as a primary indicator of market demand for the company's core life sciences offerings and therapeutic support programs.